Načítá se...
MNGI-12. EXPRESSION OF PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) IN MENINGIOMA: CLINICAL UTILITY FOR PREDICTION OF TUMOR RECURRENCE AND ASSOCIATION WITH HYPOXIC RESPONSE AND NFKB2 ACTIVATION
Tumor recurrence is one of the most important clinical challenges in the management of meningioma patients. Prognostic significance of PD-L1 as a driver for immunosuppressive response and predictor for tumor growth has been demonstrated in several malignancies. We studied the prognostic role of PD-L...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217317/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.628 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|